Variant · Snv
MLH1 T117M
CI-VAR-00004263Explore in graph →NP_000240.1:p.Thr117MetNM_000249.3:c.350C>TClinVar 17094 CIViC 743 rs63750781
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 25111426
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Colorectal Neoplasm1 | ||||||||
| MLH1 T117M | (oncogenic) | Oncogenic | C | Supports Oncogenicity | 1 | accepted | EID1806MLH1 T117M (c.350C > T), identified in three cases of microsatellite-unstable colorectal cancer, was confirmed to be somatic in patients with suspected Lynch Syndrome (LS). The patients were therefore… (full text at CIViC) PMID 25111426 · Geurts-Giele et al., 2014 · Open in CIViC | civic |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 17094 | Pathogenic | reviewed by expert panel | 3 | Colorectal cancer, hereditary nonpolyposis, type 2; Lynch syndrome; Lynch syndrome 1; Hereditary nonpolyposis colorectal neoplasms; Hereditary cancer-predisposing syndrome; Lynch-like syndrome; Endometrial carcinoma; Colon cancer; Inherited MMR deficiency (Lynch syndrome); Muir-Torré syndrome; Mismatch repair cancer syndrome 1; MLH1-related disorder | germline/somatic |